Authors
Loading...
Randomized trial identifies an MMAG-based risk scoring system for breast cancer prognosis, indicating significant clinical implications.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: